Company Filing History:
2 out of 321 
1 out of 1 Years Active: 2009-2010
Title: Innovations of Yong-Kyung Choe
Introduction
Yong-Kyung Choe is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of diagnostic methods and therapeutic applications. With a total of two patents to his name, his work focuses on cancer-related factors and liver disease diagnostics.
Latest Patents
One of his latest patents involves a monoclonal antibody specific for N-myc downstream regulated gene 2 (NDRG 2) protein. This invention includes a cell line producing the monoclonal antibody, a method for measuring the quantity and quality of NDRG 2 protein, and a protein chip utilizing this technology. The NDRG 2 protein, which is specifically expressed in dendritic cells differentiated from human peripheral blood monocytes, has potential applications in elucidating dendritic cell characteristics and researching intractable diseases and cancers.
Another significant patent pertains to a method for diagnosing liver diseases rapidly in their early stages. This invention features a monoclonal antibody against asialo α1-acid glycoprotein and a diagnostic strip for immunochromatography. The device is designed for convenient measurement of asialo α1-acid glycoprotein concentration, facilitating quick liver disease diagnosis.
Career Highlights
Yong-Kyung Choe has worked with prominent organizations such as the Korea Research Institute of Bioscience and Biotechnology and Neobiodigm Co., Ltd. His experience in these institutions has contributed to his expertise in biotechnology and innovation.
Collaborations
He has collaborated with notable colleagues, including Tai-Wha Chung and Eun-Young Song, enhancing the impact of his research and inventions.
Conclusion
Yong-Kyung Choe's innovative work in biotechnology, particularly in the areas of cancer research and liver disease diagnostics, showcases his significant contributions to the field. His patents reflect a commitment to advancing medical science and improving diagnostic methods.